Drugmakers Eli Lilly and Amylin Pharmaceuticals are ending their development agreement for diabetes drugs and are resolving litigation between the companies.

BING NEWS:
  • Eli Lilly’s Zepbound in shortage months after approval
    The weight loss medication Zepbound has gone into shortage just months after it was approved by the Food and Drug Administration (FDA), with its manufacturer Eli Lilly blaming the situation on ...
    04/18/2024 - 9:42 am | View Link
  • Eli Lilly subsidiary ends lucrative collaboration with Durham biotech
    A subsidiary of Eli Lilly and Co. has ended a multimillion-dollar collaboration with a Durham gene editing company. Precision BioSciences (Nasdaq: DTIL) and Eli Lilly (NYSE: LLY) in 2020 entered an ...
    04/18/2024 - 12:45 am | View Link
  • Eli Lilly's weight loss drug reduces sleep apnea, study shows
    Eli Lilly's weight loss-related drug Zepbound could potentially be used to reduce the severity of sleep apnea in adults with obesity, according to a recent study. Results of a phase three ...
    04/17/2024 - 8:46 am | View Link
  • Eli Lilly's Prevail Therapeutics Ends Gene-Editing Collaboration With Precision BioSciences
    Precision BioSciences will regain control of three preclinical in vivo gene therapy candidates, including one for Duchenne muscular dystrophy.
    04/17/2024 - 6:28 am | View Link
  • Weight loss drug Zepbound ‘significantly reduced’ sleep apnea in trials
    Eli Lilly’s weight loss drug Zepbound has been shown to “significantly reduce” obstructive sleep apnea (OSA) in adults with obesity, the company said Wednesday. Injections of tirzepatide ...
    04/17/2024 - 4:33 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News